Literature DB >> 29607196

Metastatic small bowel neuroendocrine tumour and carcinoid heart disease with aortic valve involvement-a rare occurrence.

Siang Yuin Lee1, Sheila Li1, Karan Sian1, Rosauro Mejia1.   

Abstract

Carcinoid disease of the heart commonly affects the tricuspid and pulmonary valves causing thickening and stenosis. However in very rare circumstances, the disease can also involve the mitral and aortic valves. We present an unusual case of left sided carcinoid heart disease (CHD) and triple valve replacement without the presence of proven intra-cardiac shunts or bronchial carcinoid lesions.

Entities:  

Keywords:  5-hydroxytryptamine; Carcinoid heart disease (CHD); aortic valve; mitral valve

Year:  2018        PMID: 29607196      PMCID: PMC5864599          DOI: 10.21037/jtd.2018.01.52

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  6 in total

1.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Carcinoid heart disease.

Authors:  Sanjeev Bhattacharyya; Joseph Davar; Gilles Dreyfus; Martyn E Caplin
Journal:  Circulation       Date:  2007-12-11       Impact factor: 29.690

3.  Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel).

Authors:  M S Khan; F El-Khouly; P Davies; C Toumpanakis; M E Caplin
Journal:  Aliment Pharmacol Ther       Date:  2011-05-17       Impact factor: 8.171

4.  Surgical management of left-sided carcinoid heart disease.

Authors:  H M Connolly; H V Schaff; C J Mullany; J Rubin; M D Abel; P A Pellikka
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Outcomes, risks and complications of cardiac surgery for carcinoid heart disease.

Authors:  Sanjeev Bhattacharyya; Shahzad G Raja; Christos Toumpanakis; Martyn E Caplin; Gilles D Dreyfus; Joseph Davar
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-14       Impact factor: 4.191

6.  Updated population-based review of carcinoid tumors.

Authors:  Melinda A Maggard; Jessica B O'Connell; Clifford Y Ko
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.